| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 1, 2018Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy.
DUBLIN - May 1, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic'
-
May 1, 2018
DUBLIN - May 1, 2018 - Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced expanded paid family leave benefits to allow for greater employee flexibility when...
-
May 1, 2018Medtronic Announces TiONIC(TM) Technology, a Titanium 3D Printed Platform for Spine Surgery ImplantsTechnology Allows for Creation of More Intricate Implant Designs and Surface Textures
DUBLIN and NEW ORLEANS - May 1, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of a titanium 3D printed platform - TiONIC(TM) Technology - that enables more complex designs and...
-
Apr 30, 2018Approval Adds Two Additional Implants to Current Spine Labeling
DUBLIN - April 30, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine surgery indications. InfuseBone Graft is...
-
Apr 26, 2018
DUBLIN and SAN DIEGO - April 26, 2018 - Medtronic plc (NYSE: MDT) today announced two-year outcomes for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study....
-
Apr 23, 2018New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm
DUBLIN - April 23, 2018 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon (DCB)...
-
Apr 17, 2018Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors
DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular...
-
Apr 10, 2018
DUBLIN - April 10, 2018 - Medtronic plc (NYSE: MDT) announced today the CE (Conformité Européenne) Mark and European launch of the Visualase(TM) MRI-Guided Laser Ablation System. The Visualase...
-
Apr 9, 2018Pivotal Trial Now Underway to Study Effect of Investigational Procedure in Patients with High Blood Pressure
DUBLIN - April 9, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the...
-
Apr 9, 2018Data on Implant Approach, Blood Pressure Management, Length of Stay, and Quality of Life to be Featured During Congress.
DUBLIN - April 9, 2018 - Medtronic plc (NYSE: MDT) today announced a preview of notable clinical data on the HeartWare HVAD® System that will be presented at The International Society of Heart...
-
Apr 5, 2018
DUBLIN - April 5, 2018 - Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced Laura Mauri, M.D., M.Sc., interventional cardiologist and clinical researcher at the...
-
Mar 20, 2018Positive Data on Exclusive AdaptivCRT(TM) Feature Unveiled at EHRA Scientific Sessions 2018
DUBLIN and BARCELONA, Spain - March 20, 2018 - Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial...
-
Mar 19, 2018
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM)...
-
Mar 13, 2018
DUBLIN - March 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Oppenheimer 28th Annual Healthcare Conference on Tuesday,...
-
Mar 12, 2018Medtronic Seeks Up to 20 Runners Who Benefit from Medical Technology
DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that applications are now being accepted for the 2018 Medtronic Global Champions team....
-
Mar 12, 2018'Smart' CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management
DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received U.S. Food and Drug Administration (FDA) approval...
-
Mar 10, 2018Presented at ACC.18, Five-Year Follow-up from the CoreValve Extreme Risk and NOTION Studies Show Sustained Valve Function and Durability Over Time
DUBLIN and ORLANDO - March 10, 2018 - Medtronic plc (NYSE: MDT) today unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic Aortic Valve...
-
Mar 9, 2018
DUBLIN - March 9, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 fourth quarter cash dividend of $0.46 per ordinary share, representing a 7 percent...
-
Mar 9, 2018
DUBLIN - March 9, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will answer questions about the company on Wednesday, March 14, 2018, in Miami, Florida.
-
Mar 8, 2018
DUBLIN - March 8, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 38th Annual Cowen and Company Healthcare Conference on...
-
Feb 28, 2018The Programs Are Expected to Benefit up to 500,000 Patients in Northeast Pennsylvania and Reduce Cost of Care by $100 Million
LEHIGH VALLEY, Pa. and DUBLIN - February 28, 2018 - Today, Medtronic plc (NYSE: MDT), the global leader in medical technology, and Lehigh Valley Health Network (LVHN), an eight-hospital network...
-
Feb 26, 2018
DUBLIN- February 26, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved a new arm indication...
-
Feb 26, 2018FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients
DUBLIN - February 26, 2018 - Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute...
-
Feb 21, 2018
DUBLIN - February 21, 2018 - Today, the United Kingdom's National Institute for Health and Care Excellence (NICE) issued a Medtech Innovation Briefing on the use of the Medtronic Reveal LINQ(TM)...
-
Feb 21, 2018New Infusion Set Offers Simpler, Faster, and More Convenient1 Insulin Pump Experience
DUBLIN - February 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today introduced the MiniMed(TM) Mio(TM) Advance infusion set. The MiniMed...